Connect with us

Cannabis

Does Cannabis Interact With Pharmaceutical Medications?

Published

on


By

All chemical compounds interact with other chemicals in a unique manner. This includes over-the-counter drugs and prescription pharmaceuticals all the way to illicit substances. That’s why it is important to always seek the opinion of a pharmacist before mixing any drugs, and cannabis is no exception.

Cannabis interactions have been identified to be relatively mild in most cases with the interactions being mostly favorable. This however does not mean that one should let their guard down and consume them willy nilly when they are on other medications. While most interactions are positive, others could be negative with adverse effects.

marijuana prescription
Photo by LattaPictures/Getty Images

Before we dive into a description of some of the most common drugs people have been known to combine with cannabis, let us first explain the difference between “synergistic” and “additive” effects. When a compound has an additive effect, what this means is that the final effect is the sum of their individual effects (I.e. 1+1=2). Synergistic effects on the other hand are altered and mostly greater than the sum of their individual effects (i.e. 1+1=3).

It is also important to keep in mind that the individual composition of each batch of weed might differ significantly from another, therefore triggering different effects.

To answer the question of whether cannabis interacts with other medicines, the answer is yes! Not only are the cannabinoid levels of the cannabis affected by interacting with other medications and drugs, the cannabinoids themselves can influence medication concentrations too.

Here are some ways in which this interaction happens:

Pharmacodynamic interactions: Cannabis can interfere with the way a drug is designed to interact with its target receptors. This interference could either hinder or potentiate the effects of the drug.

Pharmacokinetic interactions: The compounds in cannabis can also change the way in which the drug gets absorbed, metabolized, absorbed by tissue in the body, and excreted. The effect of the cannabis compounds changes the expression of different enzymes which either induces (exhibits higher activity) or inhibits them.

Inhibiting membrane transporters: Cannabis compounds can also have the effect of binding to membrane transporters, thereby inhibiting them.

Effect of drugs on cannabinoid levels: When drugs such as the antifungal ketoconazole are administered, both the levels of THC and CBD shoot up drastically, sometimes to even double the intake. This is because of the inhibitory action ketoconazole has on the enzyme CYP34A. Verapamil and macrolides are other CYP34A inhibitors which would also produce the same effect. Other enzyme inhibitors that affect CYP2C9 are cotrimoxazole, amiodarone, and fluoxetine. This spike not only increases chances of experiencing side effects, it also augments THC’s psychoactive effects.

Effect on cannabinoids on the levels of other drugs: Not only does the presence of some drugs increase cannabinoid levels in the body, the cannabis compounds can also influence the concentration of some medications. For instance, CBD inhibits the action of CYP2C9, which in turn leads to tripling levels in the active metabolite contained in the drug clobazam. THC on the other hand is a CYP1A2 inducer. What this means is that it could theoretically decrease the concentrations of some psychiatric drugs such as haloperidol, olanzapine, and chlorpromazine. CBD is also a potent inhibitor of the enzyme CYP3A4 which is responsible for metabolizing almost a quarter of all drugs.

marijuana capsules
Photo by megaflopp/Getty Imagess

This effect is also observed in the use of marijuana with the anticoagulant drug, warfarin. In this case, INR, the blood clotting parameter goes very high, which results in the potential for markedly more significant bleeding complications. CYP3A4/5 inhibition after the use of cannabis with tacrolimus has indicated an almost three-fold spike in the tacrolimus levels.

Marijuana inhalation and drug clearance: Marijuana that is smoked accelerates the removal by over 40% of bronchodilators such as theophylline from the body.  This is as a result of enhanced CYP1A2 activity. This effect can also be seen in individuals who indulge in smoking more than a couple of joints a week when taking drugs like olanzapine and clozapine. In this instance, smoking marijuana leads to reduced efficacy of the drug.

RELATED: Drugs You Don’t Want To Mix With Marijuana

Marijuana’s additive effects: As we mentioned earlier, marijuana can have additive effects when used with some drugs. For instance, marijuana combined with drugs that stimulate or mimic sympathetic activity, like amphetamines, may cause the patient to experience either symptomatic or even hazardous tachycardia or hypertension. Cannabis used with drugs which inhibit the central nervous system such as opioid drugs or alcohol could depress the central nervous system even more, leading to sleepiness, drowsiness, and ataxia.

When marijuana is used together with drugs which inhibit cholinergic receptors, the tachycardia and confusion which occur with the use of these drugs may worsen.

Marijuana and sedatives: The effect of marijuana on sedatives is also an additive one. Many sedatives like alcohol, benzodiazepines (Valium, Ativan, etc.), as well as some antidepressants and barbiturates like phenobarbital, and narcotics like codeine–influence the GABA neurotransmitters found in the central nervous system, which produces a calming effect. Likewise, cannabinoids (and even terpenes such as myrcene), also have their own sedative effects, depending on strain and concentrations of cannabinoids.

When such cannabinoids are combined with sedatives, an additive effect is created. While it does not have a synergistic effect like say mixing sedatives and alcohol, cannabis does add to the effect and should therefore be used in combination judiciously.

RELATED: Is It Safe To Use Cannabis With ADHD Medications?

CBD and cytochrome P450: We have already discussed the action of cannabis on some enzymes. Of all the enzymes marijuana affects, its effect on Cytochrome P450 might just be the most prominent yet. P450 is a class of enzymes considered to be essential which play a vital role in drug interactions. Although evidence strongly suggests that CBD is well-tolerated, generally safe, and non-addictive (anti-addictive even), it has been known to interact synergistically (adversely or beneficially) with other medications in some patients. How so?

Most notably is the interplay between cytochrome P450 and CBD in the use of anti-seizure, and epilepsy medications. A small study that was published in 2015 found the intake of CBD elevated the blood concentrations of clobazam (which is an anticonvulsant), in children, at the same time elevating norclobazam (which is an “active metabolite of clobazam”).

The good news here is that the remedy seems to be fairly straightforward: the introduction of CBD can lead to the reduction of the dosage of clobazam, which is beneficial in reducing side effects. The benefits of these combinations even extended to a reduction in seizures, with 9 out of the 13 participants experiencing a 50%+ reduction in seizures. The researchers therefore concluded that “CBD used in combination with clobazam, is a safe and effective treatment of refractory epilepsy.”

prescription drugs cannabis
Photo by FatCamera/Getty Images

How Does THC Interact With Other Medications?

One of THC’s major properties is that it interacts with both CB1, and CB2 cannabinoid receptors simultaneously. This induces a “cardiovascular stress response” which can raise cardiac oxygen consumption, and at the same time reduce blood flow into the coronary arteries. Though reports of adverse effects are relatively rare, if patients are on blood pressure medication, they should be aware of the compound effects cannabis may have.

As we have seen with CBD, THC could also increase the effect of blood thinning drugs (e.g. warfarin or heparin), or those which are known to carry their own risk of blood thinning such as  ibuprofen, and naproxen, etc. This could happen by cannabis slowing down the metabolism of the drugs or to a lesser extent, THC could displace the warfarin from protein binding sites.

Using CBD Safely While Taking Other Medications

CBD has several therapeutic benefits that are being revealed by science. The fact that it has a very wide safety profile has made many people erroneously believe that there’s totally no risk in mixing CBD with pharmaceuticals.

If you are thinking about trying CBD as an “add-on therapy” to ease the symptoms of a  medical condition, here are a couple of considerations to have in mind:

  • First talk to your doctor about your decision. They might be to determine a schedule, CBD product, and dosage that would be appropriate for your medications. In some cases, your doctor may choose to monitor your blood plasma levels depending on the medications you are taking.
  • Don’t stop any medications you are taking for substitution with CBD unless your doctor says that it is expressly okay to do so.
  • Topical CBD solutions such as creams, lotions, and salves can be an option. Unlike edibles, vaping solutions, and oils, topicals typically do not get into your bloodstream and would therefore react less. This is especially true for topicals that are not intended to be a transdermal solution.
  • Look out for the grapefruit warning: Even though studies are still being done to determine the potential interactions between specific medications and CBD, it is a general rule of thumb to avoid CBD if your medications contain a grapefruit warning on their label. If you are taking CBD, you should avoid medications that have a grapefruit warning because chemicals found in grapefruit called furanocoumarins inhibit CYP3A4, much in the same way that CBD does. The result of this inhibition is slowed metabolization of medications.

Some of the medications that commonly have a grapefruit warning are:

  • Antibiotics and antimicrobials
  • Anticancer medications
  • Antihistamines
  • Antiepileptic drugs (AEDs)
  • Blood pressure medications
  • Blood thinners
  • Cholesterol medications
  • Corticosteroids
  • Erectile dysfunction medications
  • GI medications, like some used to treat nausea or GERD
  • Heart rhythm medications
  • Immunosuppressants
  • Mood medications, used to treat depression, anxiety, or mood disorders
  • Pain medications
  • Prostate medications
CBD oil
Photo by LightFieldStudios/Getty Images

Safety and Side Effects

If you have started taking CBD alongside your medications, always remember to look out for changes in how either the CBD or medication affect you. Some side-effects you could watch out for are:

  • Drowsiness
  • Sedation
  • Nausea
  • Decrease in the effectiveness of the medication like breakthrough seizures
  • Fatigue
  • Diarrhea
  • Changes in appetite
  • Changes in weight

How Does Cannabis Interact With Thyroid Medications? 

Hashimoto’s thyroiditis, which is also called autoimmune or “chronic lymphocytic thyroiditis”, is the most commonly occurring form of thyroiditis. CBD oil has been known to have positive effects in this condition due to its anti-inflammatory properties as well as its ability to be an immunosuppressant.

However, when thyroid medication and CBD oil are taken together, they tend to have an interaction as they are both competing for metabolism. Remember the cytochrome P450 pathways? This competition would lead to hyperthyroidism as thyroxine would end up accumulating in the body before it has a chance to metabolize it. Taking thyroid medication and CBD oil too close together could also lead to mild nausea, as well as anxiety in some patients.

RELATED: The Most Expensive Weed You Can Buy (And How To Make Your Own At Home!)

Interestingly, if a few hours are allotted between the time the thyroid medication is taken and the time the CBD oil is taken, the effects seem to be less common. This could indicate that the two treatments can be taken by the same person as they have different benefits, only not at the same time.

Having said this, it is important to remember that there are not many conclusive studies on the subject and therefore it would be wise to tread with a bit of caution.

Should You Take Paracetamol When Stoned?

Absolutely yes! Though the paracetamol might potentiate the effects of the cannabis, it certainly is not harmful. If you feel that you need to take some painkillers before you smoke your weed, you could do so. Take a few tokes and wait a little to observe the effects. If you seem to be tolerating it well, you can go ahead and finish the whole joint.

Conclusion

For most patients, CBD and cannabis are relatively safe. Nonetheless, cannabis happens to be a complex plant that comprises numerous compounds ranging from cannabinoids to terpenes. Influenced by these vast cannabinoid and terpene profiles, potential interactions with different drugs could be both good and bad and vary significantly from strain to strain.

In this regard, though some general conclusions can be made, drawing broad hypotheses to describe how cannabis will interact with cannabis can be inevitably misleading.

This article originally appeared on MyCannabis.com and has been reposted with permission.



Source link

Continue Reading

Cannabis

White House Finally Comments On Marijuana Industry

Published

on

By


Part of the cannabis industry supported the new president, betting he was going to move and move quickly on cannabis – the White House finally commented.

The cannabis industry has been a boon for consumers, medical patients, veterans and legal states, but for the thousands of mom and pop businesses is has been a roller coaster.  With a huge demand, it would seem to be easy money, but the federal, tax, and banking restrictions have made it difficult to grow and expand. Part of the industry were all for the new administration assuming they would support positive change, but many in the new cabinet and the House Speaker Mike Johnson are foes.  Now the White House finally comments on marijuana industry…and it doesn’t show a clear path.

RELATED: Music Is A Turn On Like Sex And Marijuana

The administration’s current stance on marijuana reform is marked by inaction, despite campaign promises and earlier signals of support for cannabis-related reforms. A White House official recently confirmed that “no action is being considered at this time” regarding marijuana policy, leaving advocates and industry stakeholders uncertain about the administration’s priorities.

During his campaign, the resident expressed support for rescheduling marijuana under the Controlled Substances Act (CSA), which would move it from Schedule I to Schedule III, easing restrictions on medical use and enabling cannabis businesses to access banking and tax benefits. However, since taking office, no concrete steps have been taken to advance this initiative. A DEA hearing on rescheduling, initially planned for January 2025, was postponed due to procedural appeals and remains unscheduled.

The president has also voiced support for state autonomy in cannabis policy and endorsed state-level legalization initiatives, such as Florida’s failed 2024 ballot measure for recreational marijuana. While this reflects a more favorable stance compared to his first term, his administration has yet to prioritize federal reforms like the SAFE Banking Act, which would facilitate banking services for cannabis businesses. Efforts to include such measures in a government funding bill late last year were unsuccessful.

The delay in federal action has significant implications for the cannabis industry. Rescheduling marijuana could alleviate financial burdens by eliminating restrictions under IRS Code Section 280E and promoting medical research. However, the stalled process leaves businesses navigating regulatory uncertainties and limited financial access.

RELATED: The Science Behind Why Music Sounds So Much Better When You’re High

While stakeholders continue lobbying for reform, the administration appears focused on other priorities such as immigration and foreign policy. Advocates hope the President will leverage his influence to advance cannabis reform, but for now, the issue remains sidelined. Until then the industry struggles and waits.



Source link

Continue Reading

Cannabis

This State’s Cannabis Revenue Keeps Pouring In

Published

on

By


States are starting to scramble with looming budget deficients, but marijuana is a boon to some – especially one state.

The new federal administration is revamping how the government operates. With Doge, they are changing agencies and reducing services and support of states, which has left budget deficients in many. But some states have legal marijana and it has been a boon, for like alcohol…people are still consuming. States who are fully legal are making more money on weed than booze and this state’s cannabis revenue keeps pouring in. Missouri, the show me state, is being shown unexpected revenue.

RELATED: Mike Johnson And Marijuana

“Due to a strong cannabis market and effective, efficient regulation of that market,” Amy Moore, director of the Missouri Division of Cannabis Regulation, told The Independent this week, “the funds available for the ultimate beneficiaries of the cannabis regulatory program continue to outpace expectations.”

Funds will help veterans and other key projects. The other benefit is as seen in data from legal states, teen use is down so it frees up some other funds.  Legal states are seeing benefits from legal cannabis including lower teen use and crime reduction.

States with legal cannabis are experiencing a significant boost in tax revenue, surpassing those generated by alcohol sales. This trend highlights the economic benefits of marijuana legalization, as cannabis markets expand and mature.

In California, cannabis excise taxes have consistently outperformed alcohol-related taxes, bringing in over double the revenue. Colorado has seen even more striking results, with marijuana tax revenues totaling seven times those of alcohol. Similarly, Massachusetts has collected more tax revenue from marijuana than alcohol since fiscal year 2021, marking a notable shift in state finances.

RELATED: Marijuana Use And Guy’s Member

Nationally, legal cannabis states generated nearly $3 billion in excise taxes on marijuana in 2021—20% more than alcohol taxes. By 2024, total adult-use cannabis tax revenue exceeded $20 billion, with states like Illinois and Washington reporting record-breaking contributions. Illinois alone collected $451.9 million from cannabis taxes in fiscal year 2022—one-and-a-half times the revenue from alcohol.

The funds are being put to good use. States like Illinois are channeling marijuana tax dollars into mental health services and community programs, while Colorado has invested nearly $500 million into public education. California has allocated millions to nonprofits addressing the impacts of the war on drugs.

This growing revenue stream underscores the potential of cannabis legalization to support vital public services and bolster state economies. As more states embrace regulated marijuana markets, the financial benefits are expected to continue flourishing.



Source link

Continue Reading

Cannabis

Mixed Messages From The Feds About Cannabis

Published

on

By


The federal administration is all over the board around fed cannabis policy…and millions of patients are worried.

The industry employees over 440,000 workers at all lives and is driven in a large part by mom and pop businesses.  Millions use medical marijuana for health issues ranging from chronic pain to sleep.  But there are mixed messages from the feds about cannabis, and people are very worried. The federal government’s stance on marijuana has become increasingly complex, as recent developments show conflicting approaches to the drug’s potential benefits and risks. On one hand, there’s a push for research into medical marijuana for veterans, while on the other, a campaign against cannabis use is being launched.

RELATED: Music Is A Turn On Like Sex And Marijuana

The juxtaposition of initiatives highlights the federal government’s inconsistent approach to marijuana policy. While some departments are exploring the potential benefits of cannabis, others are actively working to discourage its use. This dichotomy is further exemplified by ongoing legislative efforts. For instance, Rep. Brian Mast (R-FL) has reintroduced the Veterans Equal Access Act, which would allow VA doctors to recommend medical marijuana to patients in states where it’s legal. Meanwhile, documents from an ongoing lawsuit suggest that the DEA may have weighted the marijuana rescheduling process to ensure rejection of moving the drug from Schedule 1 to Schedule 3.

Photo by yavdat/Getty Images

The Department of Defense (DOD) has allocated nearly $10 million in funding for research into the therapeutic potential of MDMA for active-duty military members. This initiative, driven by congressional efforts, aims to explore MDMA’s effectiveness in treating conditions such as post-traumatic stress disorder (PTSD) and traumatic brain injury (TBI). Rep. Morgan Luttrell (R-TX) expressed pride in this development, stating that it could be a “game-changer” for service members battling these combat-related injuries.

Additionally, a bipartisan effort in Congress has been pushing for VA research on medical marijuana for PTSD and other conditions affecting veterans. The VA Medicinal Cannabis Research Act, introduced in both the Senate and House, would mandate studies on how cannabis affects the use of addictive medications and impacts various health outcomes for veterans.

RELATED: The Science Behind Why Music Sounds So Much Better When You’re High

In stark contrast to these research initiatives, the Drug Enforcement Administration (DEA) has partnered with an anti-cannabis nonprofit to launch a social media campaign targeting young people. The campaign, set to run ahead of April 20 (4/20), aims to “flood” Instagram with anti-cannabis content. The DEA is offering monetary incentives to students for creating and posting anti-THC videos, with payments ranging from $25 to $50 depending on the type of content produced.

This approach has raised eyebrows, as it seems to contradict the growing acceptance and legalization of marijuana across the United States. Critics argue that such campaigns may be out of touch with current societal trends and scientific understanding of cannabis.



Source link

Continue Reading
Advertisement

Trending

Copyright © 2021 The Art of MaryJane Media